» Articles » PMID: 27771799

Salbutamol Effects on Systemic Potassium Dynamics During and Following Intense Continuous and Intermittent Exercise

Overview
Specialty Physiology
Date 2016 Oct 25
PMID 27771799
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Salbutamol inhalation is permissible by WADA in athletic competition for asthma management and affects potassium regulation, which is vital for muscle function. Salbutamol effects on arterial potassium concentration ([K]) during and after high-intensity continuous exercise (HI) and intermittent exercise comprising repeated, brief sprints (HI), and on performance during HI are unknown and were investigated.

Methods: Seven recreationally active men participated in a double-blind, randomised, cross-over design, inhaling 1000 µg salbutamol or placebo. Participants cycled continuously for 5 min at 40 % [Formula: see text]O and 60 % [Formula: see text]O, then HI (90 s at 130 % [Formula: see text]O), 20 min recovery, and then HI (3 sets, 5 × 4 s sprints), with 30 min recovery.

Results: Plasma [K] increased throughout exercise and subsequently declined below baseline (P < 0.001). Plasma [K] was greater during HI than HI (P < 0.001, HI 5.94 ± 0.65 vs HI set 1, 4.71 ± 0.40 mM); the change in [K] from baseline (Δ[K]) was 2.6-fold greater during HI than HI (P < 0.001). The Δ[K] throughout the trial was less with salbutamol than placebo (P < 0.001, treatment main effect, 0.03 ± 0.67 vs 0.22 ± 0.69 mM, respectively); and remained less after correction for fluid shifts (P < 0.001). The Δ[K] during HI was less after salbutamol (P < 0.05), but not during HI. Blood lactate, plasma pH, and the work output during HI did not differ between trials.

Conclusions: Inhaled salbutamol modulated the [K] rise across the trial, comprising intense continuous and intermittent exercise and recovery, lowering Δ[K] during HI. The limited [K] changes during HI suggest that salbutamol is unlikely to influence systemic [K] during periods of intense effort in intermittent sports.

Citing Articles

A century of exercise physiology: effects of muscle contraction and exercise on skeletal muscle Na,K-ATPase, Na and K ions, and on plasma K concentration-historical developments.

McKenna M, Renaud J, Ortenblad N, Overgaard K Eur J Appl Physiol. 2024; 124(3):681-751.

PMID: 38206444 PMC: 10879387. DOI: 10.1007/s00421-023-05335-9.


Oral digoxin effects on exercise performance, K regulation and skeletal muscle Na ,K -ATPase in healthy humans.

Sostaric S, Petersen A, Goodman C, Gong X, Aw T, Brown M J Physiol. 2022; 600(16):3749-3774.

PMID: 35837833 PMC: 9541254. DOI: 10.1113/JP283017.


A single oral glucose load decreases arterial plasma [K ] during exercise and recovery.

Steward C, Smith R, Stepto N, Brown M, Ng I, McKenna M Physiol Rep. 2021; 9(11):e14889.

PMID: 34110701 PMC: 8191174. DOI: 10.14814/phy2.14889.


Regulation of muscle potassium: exercise performance, fatigue and health implications.

Lindinger M, Cairns S Eur J Appl Physiol. 2021; 121(3):721-748.

PMID: 33392745 DOI: 10.1007/s00421-020-04546-8.

References
1.
Gullestad L, Hallen J, Sejersted O . K+ balance of the quadriceps muscle during dynamic exercise with and without beta-adrenoceptor blockade. J Appl Physiol (1985). 1995; 78(2):513-23. DOI: 10.1152/jappl.1995.78.2.513. View

2.
Hostrup M, Kalsen A, Bangsbo J, Hemmersbach P, Karlsson S, Backer V . High-dose inhaled terbutaline increases muscle strength and enhances maximal sprint performance in trained men. Eur J Appl Physiol. 2014; 114(12):2499-508. DOI: 10.1007/s00421-014-2970-2. View

3.
Bennett J, Tattersfield A . Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Thorax. 1997; 52(5):458-64. PMC: 1758570. DOI: 10.1136/thx.52.5.458. View

4.
Collomp K, Le Panse B, Portier H, Lecoq A, Jaffre C, Beaupied H . Effects of acute salbutamol intake during a Wingate test. Int J Sports Med. 2005; 26(7):513-7. DOI: 10.1055/s-2004-821223. View

5.
Clausen T . Excitation-induced exchange of Na+, K+, and Cl- in rat EDL muscle in vitro and in vivo: physiology and pathophysiology. J Gen Physiol. 2013; 141(2):179-92. PMC: 3557307. DOI: 10.1085/jgp.201210892. View